This backflow, called regurgitation, can put extra strain on your heart. The strain can increase even more during pregnancy when your blood volume increases. Mild regurgitation is usually not a ...

Background Pulmonary hypertension (PHT) lacks community prevalence and outcome data. Objective To characterise minimum ‘indicative’ prevalences and mortality data for all forms of PHT in a selected ...

The Centers for Medicare & Medicaid Services (CMS) has announced its proposed decision memo for the coverage of transcatheter edge-to-edge repair (TEER) for the treatment of symptomatic tricuspid ...

Get Instant Summarized Text (Gist) Minimally invasive valve repair using a clip significantly reduces heart failure hospitalizations in patients with severe tricuspid regurgitation. At two years ...

25). “At two years, transcatheter edge-to-edge repair (TEER) for the treatment of symptomatic, severe tricuspid regurgitation appears to be safe, significantly reduced symptom severity and decreased ...

Background: One-year outcomes of the TRILUMINATE Pivotal trial found that transcatheter edge-to-edge repair (TEER) for the treatment of severe, symptomatic tricuspid regurgitation (TR) improved ...

The ALIGN-AR trial contributes to the literature by demonstrating high technical success, a reassuring safety profile, and favorable clinical outcomes in high-risk patients with aortic regurgitation ...

The phase IIIb trial could mark another entry in the wave of evidence for an exciting class of injectables with approved cardiovascular and weight loss applications beyond glycemic control.

WASHINGTON − The Justice Department is considering merging the lead agencies enforcing drug and gun laws in a major shakeup as it moves to follow President Donald Trump's instructions to sharply ...

Tech Moves covers notable hires, promotions and personnel changes in the Pacific NW tech community. Submissions: [email protected] Teresa Hutson. (LinkedIn Photo) Microsoft’s Teresa Hutson has ...

using the TriClip system is safe and effective for patients with severe tricuspid regurgitation (TR) and endocardial leads, achieving significant symptom relief and TR reduction without lead-related ...

The funding will be put towards an early feasibility study, designed to determine the clinical effectiveness and safety of Laplace’s transcatheter tricuspid valve replacement system. If ...